Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Rotarix in Healthy Infants (Rota-036)
NCT00140686Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2004
- Primary completion
- Aug 2006
- Modality
- Live Attenuated Vaccines
- Countries
- 6
01
Overview
A Phase 3 trial of human rotavirus vaccine, live attenuated in rotavirus gastroenteritis, sponsored by GSK. Started Sep 2004; status: completed.
02
Drugs
human rotavirus vaccine, live attenuated
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT00140686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140686.